Study Details

Open

ETERNITY: Biorepository to accelerate advances in Radiation Therapy

To develop a prospective Radiation Oncology biorepository inclusive of pertinent biospecimen samples from patients evaluated for cancer- or tumor-directed therapy at timepoints including prior to, on-, and post- treatment.

Age & Gender

0 years ~ 99 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)
Visits can be combined with regular clinical appointments

Location

North Carolina (Statewide)

What will be asked of you

This study aims to develop therapy and tests for the treatment and diagnosis of cancer. This study will focus on cancers that are often treated with radiation therapy. To participate on the study, you will meet with a member of the study team either during your already scheduled appointments or you will schedule a separate time to meet with the study team to coordinate the collection of the biospecimen. addition to your oncology care team. The study involves providing your specimens that have already been or will be collected as part of your standard of care appointments. Additionally, you will be given the option to provide research-only biospecimen samples that are collected outside of standard of care appointments.

In-person visits:
1-5

Phone or online visits:
2-3

Total length of participation:
10 years

Looking for Specific Volunteers

Able to participate:

Written informed consent OR written assent and parental consent obtained to participate in the study and HIPAA authorization for release of personal health information
Subjects must have undergone diagnostic procedure (e.g., CT or MRI imaging) appropriate to the clinical situation, that documents disease status.
Willingness to provide one of the following: blood, or extra tissue from previous or upcoming standard-of-care biopsy or surgery, or blood from a research-only visit.
Subject is planning or considering cancer- or tumor-directed therapy with our multidisciplinary clinics for the management of their disease

Not eligible if:

Patient unwilling or unable to complete informed consent.
Physician request that patient not be enrolled into study.
Physical/psychological inability to complete sample collection for any reason including but not limited inability inability

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

Lineberger Comprehensive Cancer Center
NC Cancer Hospital (Basnight)
UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Shivani Sud
Radiation Oncology - Chapel Hill

Study Type

Clinical or Medical
Observational

Study Topics

Cancer (Bladder, Brain and Other Nervous System, Breast, Colorectal, Cervical, Head and Neck, Kidney, Liver, Lung, Melanoma, Pancreatic, Pediatric Cancers, Prostate, Sarcoma (bone and soft tissue), Stomach and Esophageal, Thyroid and Other Gland/Endocrine, Other Cancers, Leukemia, Phase 1 Trials (all cancers), Lymphoma, Multiple Myeloma, Uterine (endometrial), Ovarian)
Child and Teen Health

IRB Number

23-1124